Josh Hardman headshot photo, 2025.

Josh Hardman is the Founder & Editor of Psychedelic Alpha and an advisor, speaker, and expert covering psychedelic drug development, research, and policy.

Psychedelic Alpha

Since founding the outlet in 2020, Hardman has written hundreds of analyses and built the field’s most relied-upon data resources tracking psychedelic drug development, policy, and investment activity.

Today, Psychedelic Alpha is read by investment firms, biotechs and pharmaceutical companies, philanthropies and regulators, clinicians and researchers alike.

Consulting and Advisory

Hardman works with individuals and organisations seeking to understand the psychedelics field, stay closely informed, and gain perspective on complex or emerging challenges.

Engagements range from one-off research calls to retainer-based advisory, and from one-to-one strategy sessions to corporate briefings for hundreds. Over the past half-decade he has advised investors, philanthropists, government agencies, startups, and large firms.

Speaking & Expert Engagements

Hardman is an active speaker, lecturer, interviewee, and expert reviewer. Recent appearances and engagements include:

  • Expert Witness and Reviewer / UK Parliamentary Office of Science and Technology (Westminster, UK)

  • Guest Lecturer / University of Wisconsin Madison’s Master’s in Psychoactive Pharmaceutical Investigation (Madison WI, U.S.)

  • Guest Lecturer / Monash University (Melbourne, Australia)

  • Guest Lecturer / Columbia University (New York, NY, U.S.)

  • External Review Group Member / World Health Organisation guideline on balanced national controlled medicines policies to ensure medical access and safety

  • Expert Witness / MEP Action Group for the Medical Use of Psychedelics (European Parliament, Brussels)

  • Invited Expert / University of Birmingham Institute of Advanced Studies Psychedelics Roundtable (Birmingham, UK)

  • Keynote Speaker / Borealis Conference (Stockholm, Sweden)

  • Speaker / The REAL Mental Health Summit (London, UK)

  • Speaker & Mentor / SXSW 2023 (Austin TX, U.S.)

  • Convenor, Speaker / SOCAP Social Impact Summit (San Francisco CA, U.S.)

  • Keynote Speaker / Psychedelic Science (Denver CO, U.S.)

  • Speaker / reMind (Las Vegas NV, U.S.)

  • Speaker / PSYCH Symposium (London, UK)

  • Keynote Speaker / Interdisciplinary Conference on Psychedelic Research (Haarlem, the Netherlands)

  • Keynote Speaker / Horizons (New York NY, U.S.)

  • Expert Witness / Centre for Evidence Based Drug Policy (Westminster, London, UK)

  • Podcast and Radio Guest / Various

  • Media Interviews / Quoted in BBC, AP, Axios, Wired, etc.

  • Expert Interviewee/European Psychiatric Association

  • Speaker/ Academy of Management (Copenhagen, Denmark)

  • Expert/ EU-Funded PsyPal Design Workshop (Barcelona, Spain)

  • Speaker / UW-Madison Psychedelic Symposium (Madison WI, U.S.)

  • Speaker / Harvard University (Cambridge MA, U.S.)

  • Speaker / The Psychedelic Therapeutics and Drug Development Conference (New Orleans LA, U.S.)